Literature DB >> 22056869

Authorship and the role of medical writers.

A J Lotery.   

Abstract

Mesh：

Year:  2011        PMID： 22056869      PMCID： PMC3259592          DOI： 10.1038/eye.2011.262

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

Review 1.  Central serous chorioretinopathy following oral tadalafil.

Authors:  P Gordon-Bennett; T Rimmer
Journal:  Eye (Lond)       Date:  2011-11-04       Impact factor: 3.775

2.  Comment on 'Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab'.

Authors:  J H Vallance
Journal:  Eye (Lond)       Date:  2011-11-04       Impact factor: 3.775

3.  Authors' Submission Toolkit: a practical guide to getting your research published.

Authors:  Leighton Chipperfield; Leslie Citrome; Juli Clark; Frank S David; Robert Enck; Michelle Evangelista; John Gonzalez; Trish Groves; Jay Magrann; Bernadette Mansi; Charles Miller; LaVerne A Mooney; Ann Murphy; John Shelton; Philip D Walson; Al Weigel
Journal:  Curr Med Res Opin       Date:  2010-08       Impact factor: 2.580

4.  Research Methods & Reporting. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines.

Authors:  Chris Graf; Wendy P Battisti; Dan Bridges; Victoria Bruce-Winkler; Joanne M Conaty; John M Ellison; Elizabeth A Field; James A Gurr; Mary-Ellen Marx; Mina Patel; Carol Sanes-Miller; Yvonne E Yarker
Journal:  BMJ       Date:  2009-11-27

Review 5.  Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab.

Authors:  C H Meyer; F G Holz
Journal:  Eye (Lond)       Date:  2011-04-01       Impact factor: 3.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.